Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (1)

Search Parameters:
Keywords = somatostatin-dopamine chimeric compounds

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
18 pages, 1300 KiB  
Review
Somatostatin-Dopamine Chimeric Molecules in Neuroendocrine Neoplasms
by Maria Celeste Cantone, Alessandra Dicitore and Giovanni Vitale
J. Clin. Med. 2021, 10(3), 501; https://doi.org/10.3390/jcm10030501 - 1 Feb 2021
Cited by 13 | Viewed by 4677
Abstract
Neuroendocrine neoplasms (NENs) are a widely heterogeneous family of neoplasms arising from neuroendocrine cells, which are interspersed throughout the body. Despite NENs are relatively rare, their incidence and prevalence are constantly increasing probably due to the improvement in earlier diagnosis and patients’ management. [...] Read more.
Neuroendocrine neoplasms (NENs) are a widely heterogeneous family of neoplasms arising from neuroendocrine cells, which are interspersed throughout the body. Despite NENs are relatively rare, their incidence and prevalence are constantly increasing probably due to the improvement in earlier diagnosis and patients’ management. When surgery is not curative, particularly for patients with metastatic disease, several medical options are available. Somatostatin analogues (SSA) are the first-line medical therapy for well-differentiated NENs. Interestingly, the heterodimerization of somatostatin receptors (SSTs) with dopamine receptors (DRs) has been discovered in NENs. This phenomenon results in hybrid receptors with enhanced functional activity. On these bases, chimeric molecules embracing somatostatin and dopamine features have been recently developed. The aim of this review is to provide a comprehensive overview of the available preclinical and clinical data regarding chimeric somatostatin-dopamine agonists as a new class of “magic bullet” in the therapy of NENs. Full article
(This article belongs to the Section Endocrinology & Metabolism)
Show Figures

Figure 1

Back to TopTop